| Title |
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, January 2008
|
| DOI | 10.2147/ndt.s2024 |
| Pubmed ID | |
| Authors |
Andreas Rogalewski, Jörg Kraus, Martin Hasselblatt, Christoffer Kraemer, Wolf-Rüdiger Schäbitz |
| Abstract |
We report a case of acute demyelinating encephalitis that occurred after viral vaccination against hepatitis A-, hepatitis B-, and poliovirus and vaccination against bacterial toxins of diphtheria and tetanus. After different diagnosis had been excluded, we diagnosed postvaccinal demyelinating encephalitis and started treatment with high dose intravenous methylprednisolone, followed by peroral application in decreasing dosages for three weeks. A few days after the treatment with methylprednisolone had been finished, the patient's medical condition deteriorated again. Thus, we initiated plasma exchange at an advanced state of illness, which led to significant continuous improvement. The role of plasma exchange is discussed controversially, in particular the issue of timing. We report a case that shows improvement due to plasmapheresis several weeks after symptom onset. |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Professor | 2 | 20% |
| Researcher | 2 | 20% |
| Student > Postgraduate | 2 | 20% |
| Professor > Associate Professor | 2 | 20% |
| Student > Master | 1 | 10% |
| Other | 2 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 60% |
| Neuroscience | 3 | 30% |
| Nursing and Health Professions | 1 | 10% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2021.
All research outputs
#5,240,498
of 25,374,647 outputs
Outputs from Neuropsychiatric Disease and Treatment
#734
of 3,132 outputs
Outputs of similar age
#23,137
of 168,382 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#7
of 18 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,382 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.